Main marker: Mid-pTau181

For Academic and Medical Research Institutions

Mid-pTau181 is an emerging Alzheimer’s disease biomarker.

We measure it in human plasma using ELISA.

Flexible support is available from single samples to larger batches.

 

Mid-pTau181 measuring by ELISA

Flexible support—from single samples to larger batches

 

Advancing Alzheimer’s & dementia research

Capture blood-based pathological changes for research

 

End-to-end measurement support

From inquiry through results reporting

 

We measure neurodegenerative biomarkers beyond Mid-pTau181.

Please contact us to discuss your study.